WEST PALM BEACH, FL -- Platform Specialty Products today reaffirmed its previously announced adjusted EBITDA guidance and announced preliminary results for its third fiscal quarter ended Sept. 30.
As previously announced on Oct. 7, Platform expects 2015 adjusted EBITDA in the range of $550 million to $570 million. The company's proposed previously announced acquisitions of the Electronic Chemicals and Photomasks businesses of OM Group and Alent are not reflected in the results.
Pro forma sales in its Performance Applications business unit, which includes MacDermid, are expected to be down 9.9% year-over-year, in the range of $175 million to $180 million, using actual exchange rates. Based on constant currency, sales will be down 1.4%.
The unit had a preliminary adjusted EBITDA of $52 million to $55 million, down 4.5% from a year ago. Margins were 29.7% to 30.6%, versus 28.4% a year ago.